A MALDI-TOF assay identifies nilotinib as an inhibitor of inflammation in acute myeloid leukemia and multiple myeloma.

a great paper by Rachel, Jose, Tiaan, Maria  and Joe. Congratulations!

https://www.biorxiv.org/content/10.1101/2021.03.29.437557v1